After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

Newsday Zimbabwe HEALTH and Child Care minister Douglas Mombeshora has reaffirmed the country’s commitment to advancing HIV research, treatment and global collaboration. He said this during the ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

As borders tighten, Global South citizens say they are being locked out of high-level talks that impact them the most.

Let us refresh the old gold Buddhist tale of The Quail and the Net: ldquo;Long ago a flock of quails lived in a forest .

KIGALI, July 17 (Xinhua) -- Health experts are calling on governments around the world to increase funding for HIV research and community-led responses, warning that current funding cuts risk ...

The US Senate votes to keep money for the President’s Emergency Plan for Aids Relief from a package of more than $9 billion ...

Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...

A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by. Presented ...

PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief, has been hailed as “the most important and consequential contribution to public health”, ...